PRNewsWire
12 Jun 2026, 08:05 UTC · 14w ago
Verdict
Headline takes no side. We score TWST +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 84% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Volta Labs has launched an automated App for Twist Bioscience's Fast Hybridization Kit on the Callisto Sample Prep System.
More positive than 62% of claims this week
The new automation allows labs to move from traditional overnight hybridization to a same-day, sample-to-sequencer workflow.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 50% of claims this week
Testing indicates that the automated Callisto process delivers sequencing performance and QC metrics equivalent to manual preparation.
More positive than 50% of claims this week
Which stocks this story touches
More positive than 84% of ticker scores this week
The company expanded its hybrid capture portfolio through a new automation partnership, increasing accessibility and efficiency for customers.
More positive than 43% of ticker scores this week
Mentioned as a supported sequencing platform for Volta Labs' system, indicating broad ecosystem compatibility.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+123.9%
Price agrees with the score
$165.81 vs $74.05 close before publication (Jun 11) · not market-adjusted
TWST chart →